B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis

Clinical trial NCT06612411 · RECRUITING

Trial details

NCT number: NCT06612411
Sponsor: Jinling Hospital, China
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Irritable Bowel Syndrome with Diarrhea Purine Metabolism Disorder

Start date: 2024-06-01
Primary completion: 2024-12-31
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.